193 related articles for article (PubMed ID: 2556433)
1. Comparison of immunoglobulin A (IgA), IgG, and IgM enzyme-linked immunosorbent assays, plaque reduction neutralization assay, and complement fixation in detecting seroresponses to rotavirus vaccine candidates.
Midthun K; Pang LZ; Flores J; Kapikian AZ
J Clin Microbiol; 1989 Dec; 27(12):2799-804. PubMed ID: 2556433
[TBL] [Abstract][Full Text] [Related]
2. Systemic and mucosal immune responses to rhesus rotavirus vaccine MMU 18006.
Losonsky GA; Rennels MB; Lim Y; Krall G; Kapikian AZ; Levine MM
Pediatr Infect Dis J; 1988 Jun; 7(6):388-93. PubMed ID: 2839813
[TBL] [Abstract][Full Text] [Related]
3. Detection of serum antibody responses to RIT 4237 rotavirus vaccine by ELISA and neutralization assays.
Delem A; Vesikari T
J Med Virol; 1987 Mar; 21(3):231-8. PubMed ID: 3031200
[TBL] [Abstract][Full Text] [Related]
4. Reactions to and antigenicity of two human-rhesus rotavirus reassortant vaccine candidates of serotypes 1 and 2 in Venezuelan infants.
Flores J; Perez-Schael I; Blanco M; Vilar M; Garcia D; Perez M; Daoud N; Midthun K; Kapikian AZ
J Clin Microbiol; 1989 Mar; 27(3):512-8. PubMed ID: 2541168
[TBL] [Abstract][Full Text] [Related]
5. Vaccination of Thai infants with rhesus-human reassortant tetravalent oral rotavirus vaccine.
Simasathien S; Migasena S; Samakoses R; Pitisuttitham P; Sangaroon P; Aree C; Bishop R; Bugg H; Davidson BL; Vesikari T
Pediatr Infect Dis J; 1994 Jul; 13(7):590-6. PubMed ID: 7970945
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and safety of rhesus-human rotavirus reassortant vaccines with serotype 1 or 2 VP7 specificity.
Vesikari T; Varis T; Green K; Flores J; Kapikian AZ
Vaccine; 1991 May; 9(5):334-9. PubMed ID: 1651610
[TBL] [Abstract][Full Text] [Related]
7. A comparative evaluation of the safety and immunogenicity of a single dose of unbuffered oral rhesus rotavirus serotype 3, rhesus/human reassortant serotypes 1, 2 and 4 and combined (tetravalent) vaccines in healthy infants.
Pichichero ME; Marsocci SM; Francis AB; Green JL; Disney FA; Rennels MB; Lewis ED; Sugarman L; Losonsky GA; Zito E
Vaccine; 1993; 11(7):747-53. PubMed ID: 8393606
[TBL] [Abstract][Full Text] [Related]
8. Effect of dose and a comparison of measures of vaccine take for oral rhesus rotavirus vaccine. The Maryland Clinical Studies Group.
Pichichero ME; Losonsky GA; Rennels MB; Disney FA; Green JL; Francis AB; Marsocci SM
Pediatr Infect Dis J; 1990 May; 9(5):339-44. PubMed ID: 2162027
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and reactogenicity of rhesus rotavirus vaccine given in combination with oral or inactivated poliovirus vaccines and diphtheria-tetanus-pertussis vaccine.
Jalil F; Zaman S; Carlsson B; Glass RI; Kapikian AZ; Mellander L; Hanson LA
Trans R Soc Trop Med Hyg; 1991; 85(2):292-6. PubMed ID: 1653474
[TBL] [Abstract][Full Text] [Related]
10. Seroconversion patterns to four human rotavirus serotypes in hospitalized infants with acute rotavirus gastroenteritis.
Brüssow H; Werchau H; Lerner L; Mietens C; Liedtke W; Sidoti J; Sotek J
J Infect Dis; 1988 Sep; 158(3):588-95. PubMed ID: 2842406
[TBL] [Abstract][Full Text] [Related]
11. Reactogenicity and immunogenicity of a high-titer rhesus rotavirus-based quadrivalent rotavirus vaccine.
Flores J; Perez-Schael I; Blanco M; Rojas AM; Alfonzo E; Crespo I; Cunto W; Pittman AL; Kapikian AZ
J Clin Microbiol; 1993 Sep; 31(9):2439-45. PubMed ID: 8408569
[TBL] [Abstract][Full Text] [Related]
12. Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants.
Perez-Schael I; Blanco M; Vilar M; Garcia D; White L; Gonzalez R; Kapikian AZ; Flores J
J Clin Microbiol; 1990 Mar; 28(3):553-8. PubMed ID: 2157737
[TBL] [Abstract][Full Text] [Related]
13. Determination of vaccine-induced and naturally acquired class-specific mumps antibodies by two indirect enzyme-linked immunosorbent assays.
Nigro G; Nanni F; Midulla M
J Virol Methods; 1986 May; 13(2):91-106. PubMed ID: 3016017
[TBL] [Abstract][Full Text] [Related]
14. Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity.
Vesikari T; Ruuska T; Green KY; Flores J; Kapikian AZ
Pediatr Infect Dis J; 1992 Jul; 11(7):535-42. PubMed ID: 1326741
[TBL] [Abstract][Full Text] [Related]
15. The immune response in primary asymptomatic and symptomatic rotavirus infection in newborn infants.
Losonsky GA; Reymann M
J Infect Dis; 1990 Feb; 161(2):330-2. PubMed ID: 2153740
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of antibodies to rotavirus in different age-groups of infants in Bochum, West Germany.
Brüssow H; Werchau H; Liedtke W; Lerner L; Mietens C; Sidoti J; Sotek J
J Infect Dis; 1988 May; 157(5):1014-22. PubMed ID: 2834458
[TBL] [Abstract][Full Text] [Related]
17. Rotavirus-specific breast milk antibody in two populations and possible correlates of interference with rhesus rotavirus vaccine seroconversion.
Rimer HC; Wasserman SS; Flores J; Pichichero ME; Losonsky GA
J Infect Dis; 1992 May; 165(5):826-30. PubMed ID: 1373753
[TBL] [Abstract][Full Text] [Related]
18. Comparison of reactogenicity and antigenicity of M37 rotavirus vaccine and rhesus-rotavirus-based quadrivalent vaccine.
Flores J; Perez-Schael I; Blanco M; White L; Garcia D; Vilar M; Cunto W; Gonzalez R; Urbina C; Boher J
Lancet; 1990 Aug; 336(8711):330-4. PubMed ID: 1975333
[TBL] [Abstract][Full Text] [Related]
19. Immune response of pregnant cows to bovine rotavirus immunization.
Saif LJ; Smith KL; Landmeier BJ; Bohl EH; Theil KW; Todhunter DA
Am J Vet Res; 1984 Jan; 45(1):49-58. PubMed ID: 6322624
[TBL] [Abstract][Full Text] [Related]
20. Comparison of immunogenicity and efficacy of rhesus rotavirus reassortant vaccines in breastfed and nonbreastfed children. US Rotavirus Vaccine Efficacy Group.
Rennels MB; Wasserman SS; Glass RI; Keane VA
Pediatrics; 1995 Dec; 96(6):1132-6. PubMed ID: 7491235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
